BAYLOR SCOTT & WHITE PFLUGERVILLE — History
CCN 670128 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$43M
Latest Revenue (FY2022)
+33.9%
Revenue CAGR (3yr)
4.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $40M | $43M | +10.0% | +33.9% |
| Operating Expenses | $28M | $34M | $41M | +21.7% | +20.8% |
| Operating Margin | -16.8% | 14.1% | 4.9% | -65.4% | +0.0% |
| Net Income | $-4M | $6M | $2M | -62.0% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,940 | 3,970 | 4,068 | +2.5% | +44.8% |
| Medicare Day % | 29% | 24% | 24% | -1.6% | -8.8% |
| Medicaid Day % | 1% | 0% | 0% | +192.8% | -7.3% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +79.2% ($24M → $43M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+33.9%
This Hospital
+7.6%
State Avg
Latest Margin
4.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $53M | 15.7% |
| FY2024 (proj) | $63M | 26.5% |
| FY2025 (proj) | $72M | 37.3% |